We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer.
- Authors
Fabi, Alessandra; Carbognin, Luisa; Botticelli, Andrea; Paris, Ida; Fuso, Paola; Savastano, Maria Cristina; La Verde, Nicla; Strina, Carla; Pedersini, Rebecca; Guarino, Stefania; Curigliano, Giuseppe; Criscitiello, Carmen; Raffaele, Mimma; Beano, Alessandra; Franco, Antonio; Valerio, Maria Rosaria; Verderame, Francesco; Fontana, Andrea; Haspinger, Eva Regina; Caldara, Alessia
- Abstract
This document is a correction notice for an article titled "Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer." The correction addresses an error in the author's name, where "Paola Fuso" was incorrectly written as "Paolo Fuso." The original article has been corrected. The authors of the article include Alessandra Fabi, Luisa Carbognin, Andrea Botticelli, Ida Paris, Paola Fuso, Maria Cristina Savastano, Nicla La Verde, Carla Strina, Rebecca Pedersini, Stefania Guarino, Giuseppe Curigliano, Carmen Criscitiello, Mimma Raffaele, Alessandra Beano, Antonio Franco, Maria Rosaria Valerio, Francesco Verderame, Andrea Fontana, Eva Regina Haspinger, Alessia Caldara, Alba Di Leone, Giampaolo Tortora, Diana Giannarelli, and Giovanni Scambia.
- Subjects
TRIPLE-negative breast cancer
- Publication
NPJ Breast Cancer, 2024, Vol 10, Issue 1, p1
- ISSN
2374-4677
- Publication type
Correction Notice
- DOI
10.1038/s41523-024-00619-5